Addition of plerixafor in poorly mobilized allogeneic stem cell donors.

Authors:
Zhuang L; Lauro D; Wang S; Yuan S.

Journal:
J Clin Apher

Publication Year: 2022

DOI:
10.1002/jca.21992

PMCID:
PMC9539930

PMID:
35633513

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Apher

Abbreviation: J Clin Apher

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic sc…
Kohli R; Geneen LJ; Brunskill SJ and 7 more (2022) - Transparency Score: 4/6
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegra…
Mayer W; Kontekakis A; Maas C and 3 more (2022) - Transparency Score: 3/6
Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection:…
Louw S; Jacobson BF; Mayne ES. (2022) - Transparency Score: 3/6
The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in pat…
Lopert P; Abdelrahman S; Graybill CA and 11 more (2022) - Transparency Score: 3/6
A matched cohort study of convalescent plasma therapy for COVID-19.
Sostin OV; Rajapakse P; Cruser B and 3 more (2021) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025